NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, China ...

Abstract: We introduce a flexible microfluidic bioimpedance sensor that is capable of detecting biomass and cell viability variations in a cell suspension. The sensor is developed on indium tin oxide ...

A study explains how age reshapes the blood system. In both humans and mice, a few stem cells out-compete their neighbors and gradually take over blood production. The loss of diversity results in a ...

Scedamin is a pediatric formulation of hydroxyurea being developed by Yunigen Inc. Scedamin is a pediatric formulation of hydroxyurea designed to treat children aged nine months and older who are ...

61% of those polled said they want businesses to label on products how much the price will go toward paying the tariff. “80% of Democrats, 61% of Independents, and 42% of Republicans would ...

Sickle cell disease is an autosomal recessive blood disorder that can lead to anaemia. It is caused by a mutation in the haemoglobin gene, which leads to deformation of red blood cells.

STOP = Stroke Prevention Trial in Sickle Cell Anemia; SWITCH = Stroke With Transfusions Changing to Hydroxyurea; TCD = transcranial Doppler ultrasound Imaging of the aortic arch to the ...

Hemoglobinopathies, mainly sickle cell anemia and thalassemia, are autosomal-recessive inherited disorders. Approximately 5% of the whole world population carries a potentially pathological gene.

For 21 years, Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he is the first person in New York to be cured of the disease.

Chemists found a way to identify a complex sugar molecule in the cell walls of Mycobacterium tuberculosis ... that there hasn't been an easy way to label them inside cells. MIT chemists have ...

A study of U.S. children with sickle cell disease found fewer than half get a needed screening for stroke, a common complication. Pfizer is buying sickle cell drug maker Global Blood Therapeutics ...

Fewer ED visits per year and fewer hospital days per year seen in association with hydroxyurea use. HealthDay News — For children with sickle cell anemia (SCA), hydroxyurea has sustained ...